|
|
|
|
|
|
|
|
medical news
HER4 expression may be linked to chemotherapy resistance, lower survival rate
Moffitt pathologists looked at the levels of HER4 expression in 100 ovarian serous carcinoma specimens. They found that the samples that contained the HER4 expression were linked to chemotherapy resistance and a shortened life span. This means HER4 may be a prognostic and potentially a predictive marker in ovarian serous cancer, but more studies are needed. In addition HER4 could potentially become a target for therapy.
reprinted from materials provided by H. Lee Moffitt Cancer Center & Research Institute. Note: Materials may be edited for content and length.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.